Literature DB >> 11315516

Is 4 days the minimum duration of hypomania in bipolar II disorder?

F Benazzi1.   

Abstract

DSM-IV requires that bipolar II disorder has hypomania with a minimum duration of 4 days, a cutoff not based on data. The study aim was to test if hypomania lasting 2 to 3 days could identify a group of bipolar II with typical clinical features of bipolar disorders. Consecutively, 65 unipolar and 103 bipolar II major depressive episode (MDE) outpatients were interviewed with the Structured Clinical Interview for DSM-IV. Almost all had had 2 to 3 days of hypomania, and all had had more than one hypomania. Typical clinical variables distinguishing bipolar from unipolar disorders (age at onset, atypical features, and recurrences) were compared. Bipolar II had significantly lower age at onset, more recurrences, and more atypical features. Findings suggest that hypomania lasting 2 to 3 days may identify a bipolar II group having typical features of bipolar disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11315516     DOI: 10.1007/s004060170065

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  19 in total

1.  Broadening the concept of bipolar disorder: what should be done in the face of uncertainty?

Authors:  Mark Zimmerman
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

Review 2.  Differentiating bipolar disorder-not otherwise specified and severe mood dysregulation.

Authors:  Kenneth Towbin; David Axelson; Ellen Leibenluft; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-04-04       Impact factor: 8.829

Review 3.  Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified.

Authors:  David A Axelson; Boris Birmaher; Michael A Strober; Benjamin I Goldstein; Wonho Ha; Mary Kay Gill; Tina R Goldstein; Shirley Yen; Heather Hower; Jeffrey I Hunt; Fangzi Liao; Satish Iyengar; Daniel Dickstein; Eunice Kim; Neal D Ryan; Erica Frankel; Martin B Keller
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-09-08       Impact factor: 8.829

4.  Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis?

Authors:  Giulio Perugi; Michele Fornaro; Hagop S Akiskal
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

5.  Practical Clues to Early Recognition of Bipolar Disorder: A Primary Care Approach.

Authors:  Alan C Swann; Barbara Geller; Robert M Post; Lori Altshuler; Kiki D Chang; Melissa P Delbello; Christopher Reist; Iver A Juster
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 6.  Subthreshold bipolarity: diagnostic issues and challenges.

Authors:  Robin Nusslock; Ellen Frank
Journal:  Bipolar Disord       Date:  2011 Nov-Dec       Impact factor: 6.744

7.  Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Psychiatr Res       Date:  2013-07-18       Impact factor: 4.791

8.  Mood Disorders in Family Practice: Beyond Unipolarity to Bipolarity.

Authors:  J Sloan Manning; Saeeduddin Ahmed; Hillary C. McGuire; Donald P. Hay
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-08

9.  Toward better probing for hypomania of bipolar-II disorder by using Angst's checklist.

Authors:  Franco Benazzi
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

10.  Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzu-Yun Wang; Tzung Lieh Yeh; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.